Picard Medical, Inc.
Here’s whether Picard Medical, Inc. (PMI) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: RSI 53 — healthy momentum range. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-25.34% over 10 days); 3-month momentum negative (-85.9%); rising volume on a downtrend (distribution, 2.19x avg). Currently 98.7% off its 52-week high. Score: -2/7.
PMI is trading below its 200-day MA (—) — a key warning sign the longer-term trend is under pressure. An RSI of 53.0 sits in the neutral zone — momentum is neither stretched nor exhausted. With ~9 months of trading history, the return since first available bar is -96.1%. The current 98.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.